Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132171) titled 'Pirfenidone in the Prevention and Treatment of Radiation-Induced Oral Mucositis in nasopharyngeal carcinoma patients: A randomized, controlled, multicenter phase III study' on Sept. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
nasopharyngeal carcinoma
Intervention:
Experimental group:Neoadjuvant chemotherapy combined with concurrent chemoradiotherapy plus pirfenidone
Recruitment Status: Recruiting
Phase: 3
Date of First Enrollment: 2025-10-15
Target Sample Size: Experimental group:87;Control group:87;
Countries of Recruitment:
C...